Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study

Mallen; Roddy; Belcher; Clarson; Muller

Abstract

BACKGROUND: An association between gout and renal disease is well-recognised but few studies have examined whether gout is a risk factor for subsequent chronic kidney disease (CKD). Additionally, the impact of urate-lowering therapy (ULT) on development of CKD in gout is unclear. The objective of this study was to quantify the risk of CKD stage =?3 in people with gout and the impact of ULT.

METHODS: This was a retrospective cohort study using data from the Clinical Practice Research Datalink (CPRD). Patients with incident gout were identified from general practice medical records between 1998 and 2016 and randomly matched 1:1 to patients without a diagnosis of gout based on age, gender, available follow-up time and practice. Primary outcome was development of CKD stage =?3 based on estimated glomerular filtration rate (eGFR) or recorded diagnosis. Absolute rates (ARs) and adjusted hazard ratios (HRs) were calculated using Cox regression models. Risk of developing CKD was assessed among those prescribed ULT within 1 and 3 years of gout diagnosis.

RESULTS: Patients with incident gout (n = 41,446) were matched to patients without gout. Development of CKD stage =?3 was greater in the exposed group than in the unexposed group (AR 28.6 versus 15.8 per 10,000 person-years). Gout was associated with an increased risk of incident CKD (adjusted HR 1.78 95% CI 1.70 to 1.85). Those exposed to ULT had a greater risk of incident CKD, but following adjustment this was attenuated to non-significance in all analyses (except on 3-year analysis of women (adjusted HR 1.31 95% CI 1.09 to 1.59)).

CONCLUSIONS: This study has demonstrated gout to be a risk factor for incident CKD stage =?3. Further research examining the mechanisms by which gout may increase risk of CKD and whether optimal use of ULT can reduce the risk or progression of CKD in gout is suggested.

Citation

Mallen, Roddy, Belcher, Clarson, & Muller. (2018). Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study. Arthritis Research and Therapy, 20, Article 243. https://doi.org/10.1186/s13075-018-1746-1

• Journal Article Type: Article
• Acceptance Date: Oct 15, 2018
• Publication Date: Oct 30, 2018
• Journal: Arthritis Research & Therapy
• Print ISSN: 1478-6354
• Publisher: Springer Verlag
• Peer Reviewed: Peer Reviewed
• Volume: 20
• Article Number: 243
• DOI: https://doi.org/10.1186/s13075-018-1746-1
• Keywords: gout, chronic kidney disease, urate-lowering therapy, cohort
• Publisher URL: http://doi.org/10.1186/s13075-018-1746-1